Illumina, Inc. (ILMN) stock prices updated...
Please, Signup (Login) to subscribe or trade (demo)
Illumina, Inc. stock price
Illumina, Inc. latest news:
Illumina Teams Up With Telegraph Hill to Form Verogen
Global leader in the field of DNA sequencing and array based technologies Illumina Inc ILMN along with Telegraph Hill Partners THP announced plans to set up an independent company Verogen Inc THP is a life science focused venture capital and growth equity firm based in
Illumina shares rally as revenue tops Street view
Illumina Inc. shares surged in the extended session Tuesday after the DNA sequencing company's quarterly revenue topped Wall Street estimates. Illumina shares rallied 9.5% to $188.50 after hours. The company reported second-quarter net income of $128 million, or 87 cents a share, compared to $120 million, or 82 cents a share, in the year-ago period. Adjusted earnings were 82 cents a share. Revenue rose to $662 million from $600 million in the year-ago period. Analysts surveyed by FactSet had estimated 82 cents a share on revenue of $642.2 million. For the year, Illumina estimates adjusted earnings of $3.60 to $3.70 a share. Analysts expect $3.63 a share.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Image Sensing Systems, Inc.ISNS
Immune Design Corp.IMDZ
Immune Pharmaceuticals Inc.IMNP
Impax Laboratories, Inc.IPXL
Imprimis Pharmaceuticals, Inc.IMMY
INC Research Holdings, Inc.INCR